Elevance Health
Elevance Health, Inc. (NYSE: ELV) is a U.S. health insurer and healthcare services company serving approximately 45.2 million medical members as of December 31, 2025. Its affiliated health plans offer risk-based and fee-based coverage and services to individuals, employers, Medicare and Medicaid beneficiaries, and… From the company’s description.
In fiscal 2025, Elevance Health reported revenue of $199.13B, up 12.5% from fiscal 2024, and net income of $5.66B. Its operating margin was 4.1%, and operations generated $4.29B in cash. Over the twelve months to Sep 30, 2026, revenue was $201.83B.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Elevance Health does
In the company’s own words
Elevance Health, Inc. (NYSE: ELV) is a U.S. health insurer and healthcare services company serving approximately 45.2 million medical members as of December 31, 2025. Its affiliated health plans offer risk-based and fee-based coverage and services to individuals, employers, Medicare and Medicaid beneficiaries, and federal employees. The company also provides pharmacy, behavioral health, dental, vision, stop-loss and other supplemental services to plan members and external customers. It reports four segments: Health Benefits, which provides health plans and administrative services; CarelonRx, which offers pharmacy benefits, home delivery, specialty pharmacy and infusion services; Carelon Services, which provides care management, behavioral health, provider enablement, analytics and other healthcare services; and Corporate & Other. Its core brands include Anthem Blue Cross and Anthem Blue Cross and Blue Shield, Wellpoint and Carelon. Elevance is an independent licensee of the Blue Cross and Blue Shield Association and operates under its licensed brands in multiple states.
Company details
- Sector
- Health Care
- Industry (SIC)
- Insurance
- Headquarters
- INDIANAPOLIS, IN
- Fiscal year end
- December
- CIK
- 1156039
- SIC
- 6324
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Elevance Health — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Elevance Health · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Elevance Health’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Elevance Health’s bonds, as funds hold them
Funds report holding 37 issues of Elevance Health’s debt, $4.93B at market value — what funds hold, not the company’s total debt. Weighted-average coupon 4.55%, maturing 2026 to 2064.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Elevance Health and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Elevance Health's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Elevance Health's last four quarterly filings that the numbers alone won't show?”